Effects of obstructive jaundice on the peripheral nerve: An ultrastructural study in rats

European Surgical Research

Volumn 36, Issue 4, 2004, Pages 226-233

  Can, B ^a   Saray, A ^b,d   Caglikulekci M ^c   Saran, Y ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Demyelination; Obstructive jaundice; Peripheral nerve; TNF

Indexed keywords

BILIRUBIN; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL VACUOLE; COMMON BILE DUCT; CONTROLLED STUDY; CYTOPLASM; DEMYELINATION; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HYPERBILIRUBINEMIA; KUPFFER CELL; MALE; MYELIN SHEATH; NERVE CELL DEGENERATION; NEUROPATHY; NONHUMAN; OBSTRUCTIVE JAUNDICE; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SCHWANN CELL; SCIATIC NERVE; STATISTICAL SIGNIFICANCE;

ANIMALS; BILIRUBIN; JAUNDICE, OBSTRUCTIVE; MALE; MICROSCOPY, ELECTRON; MYELIN SHEATH; RATS; RATS, WISTAR; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242788146     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078857     Document Type: Article

References (37)

1. Armstrong CP, Dixon JM, Taylor TV: Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984;71:234-238.
2. Scott-Conner CEH, Grogar JB: The pathophysiology of biliary obstruction and its effect on phagocytic and immune functions. J Surg Res 1994;57:316-336.
3. Beierle EA, Vauthey JN, Moldawer LL, Copeland EM III: Hepatic tumor necrosis factor-α production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg 1996;171:202-206.
4. Hunt DR, Allison MEM, Pentice CRM, Blumgart LH: Endotoxemia, disturbance of coagulation and obstructive jaundice. Am J Surg 1982;144:325-329.
5. Kimmings AN, van der Deventer SJH, Obertrop H, Raus EA, Huilbregtse K, Gouma DJ: Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000;46:275-731.
6. Clements WDB, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ: Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 1993;128:200-205.
7. Bemelmans MHA, Gouma DJ, Greve JW, Buurman WA: Cytokines, tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992;15:1132-1136.
8. Tu W, Kitade H, Satoi S, Zhang ZT, Kaibori M, Kwon AH, Kamiyama Y, Okumura T: Increased nitric oxide production in hepatocytes is involved in liver dysfunction following obstructive jaundice. J Surg Res 2002;106:31-36.
9. Pata C, Caglikulekci M, Cinel L, Dirlik M, Colak T, Aydin S: The effects of antithrombin-III on inducible nitric oxide synthesis in experimental obstructive jaundice. An immunohistochemical study. Pharm Res 2002;46:325-331.
10. Green J, Beyar R, Bomzon L, Finberg JPM, Better OS: Jaundice, the circulation and the kidney. Nephron 1984;37:145-152.
11. Cashore WJ, Stein L: Neonatal hyperbilirubinemia. Pediatr Clin North Am 1982;29:1191-1203.
12. Hendrickse MT, Triger DR: Peripheral and cardiovascular autonomic impairment in chronic liver disease: Prevalence and relation to hepatic function. J Hepatol 1992;16:177-183.
13. Hendrickse MT, Thuluvath PJ, Triger DR: Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992;339:1462-1464.
14. Hendrickse MT, Triger DR: Autonomic and peripheral neuropathy in primary biliary cirrhosis. J Hepatol 1993;19:401-407.
15. Bomzon A, Finberg PM, Tovbin D, Naidu SG, Better O: Bile salts, hypotension and obstructive jaundice. Clin Sci 1984;67:177-179.
16. Bemelmans MHA, Gouma DJ, Greve JW, Buurman WA: Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br J Surg 1993;80:1055-1058.
17. Brosnan CF, Selmaj K, Raine CS: Hypothesis: A role for tumor necrosis factor in immunemediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988;18:87-94.
18. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP: Tumour necrosis factor-α in immune-mediated demyelination and wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993;45:175-182.
19. Kucuk C, Ok E, Yilmaz Z, Sozuer E, Muhtaroglu S, Arar M: The effects of dimethylsulfoxide in experimental obstructive jaundice. Acta Chir Belg 2003;103:392-395.
20. Kennedy JA, Lewis H, Clements WDB, Kirk SJ, Campbell G, Halliday MI: Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg 1999;86:1410-1414.
21. Ortiz MC, Fortepiani LA, Martinez C, Atucha NM: Vascular hyporesponsiveness in aortic rings from cirrhotic rats: Role of nitric oxide and endothelium. Clin Sci 1996;91:733-738.
22. Inan M, Sayek I, Tel BC: Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br J Surg 1997;84:943-947.
23. Kimmings AN, van der Deventer SJH, Obertrop H, Rauws EA, Gouma DJ: Inflammatory and immunologic effects of obstructive jaundice: Pathogenesis and treatment. J Am Coll Surg 1995;181:567-581.
24. Kramer HJ, Schwarting K, Backer A, Meyer-Lehnert H: Renal endothelin system in obstructive jaundice: Its role in impaired renal function of bile-duct ligated rats. Clin Sci 1997;92:579-585.
25. Utkan ZN, Utkan T, Sarioglu Y, Gonullu NN: Effects of experimental obstructive jaundice on contractile responses of dog isolated blood vessels: Role of endothelium and duration of bile duct ligation. Clin Exp Pharmacol Physiol 2000;27:339-344.
26. Qi, WN, Yan ZQ, Whang PG, Zhou Q, Chen LE, Seaber AV, Stamler JS, Urbaniak JR: Gene and protein expressions of nitric oxide synthases in ischemia-reperfused peripheral nerve of the rat. Am J Physiol 2001;281:C849-C856.
27. Bagdatoglu C, Saray A, Surucu S, Ozturk H, Tamer L: Effect of trapidil in ischemia/reperfusion injury of peripheral nerves. Neurosurgery 2002;51:212-219.
28. Nukada H, McMorran PD, Shimizu J: Acute inflammatory demyelination in reperfusion nerve injury. Ann Neurol 2000;47:71-79.
29. Morgan MH, Read AE, Campbell MJ: Clinical and electrophysiological studies of peripheral nerve function in patients with chronic liver disease. Clin Sci 1979;57:31-37.
30. Nelson JS, Fitch CD, Fischer VN, Broun GO, Chou AC: Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys. J Neuropathol Exp Neurol 1981;40:166-186.
31. Guggenheim MA, Ringel SP, Silverman A, Grabert BE: Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: Diagnosis and treatment with α-tocopherol. J Pediatr 1982;100:51-58.
32. Sokol RJ, Bove KE, Heubi JE, Iannacone ST: Vitamin E deficiency during chronic childhood cholestasis: Presence of sural nerve lesion prior to 2.5 years of age. J Pediatr 1983;103:197-204.
33. Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV: Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210.
34. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-346.
35. Jenkins HG, Ikeda H: Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci 1992;108:99-104.
36. Koeppel TA, Trauner M, Baas JC, Thies JC, Schlosser SF, Post S, Gebhard MM, Herfarth C, Boyer JL, Otto G: Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology 1997;26:1085-1091.
37. Parks RW, Halliday MI, McCrory DC, Erwin P, Smye M, Diamond T, Rowlands BJ: Host immune responses and intestinal permeability in patients with jaundice. Br J Surg 2003;90:239-245.